Skip to main content

MedWellAI, Inc.

Data quality: 100%
MWAI
OTC Financial Services Nondepository Credit Institutions
$0.39
$0.00 (0.00%)
Mkt Cap: 2.42 M
Price
$0.39
Mkt Cap
2.42 M
Day Range
$0.31 — $0.31
52-Week Range
$0.20 — $0.80
Volume
2,500
Open $0.31
50D / 200D Avg
$0.44
11.27% below
50D / 200D Avg
$0.54
27.89% below

Quick Summary

Key Takeaways

Revenue declined -25.35% annually over 5 years
Negative free cash flow of -642,704.0
Revenue growth is decelerating — 1Y growth trails 5Y average by 64.51%
Capital efficient — spends only 0.00% of revenue on capex

Growth

Revenue Growth (5Y)
-25.35%
Below sector avg (5.83%)
Revenue (1Y)-89.86%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net Margin-174.02%
Op. Margin-101.58%

Safety

Debt / Equity
N/A
Current Ratio0.02
Interest Coverage-29.40

Valuation

PE (TTM)
-0.91
Below sector avg (11.15)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Financial Services sector median (2151 peers)
Metric Stock Sector Median
P/E -0.9 11.2
P/B 1.2
ROE % 9.2
Net Margin % -174.0 9.4
Rev Growth 5Y % -25.4 5.8
D/E 0.5

All Fundamental Metrics

Growth
Revenue Growth (1Y) -89.86% Revenue Growth (3Y) -60.76%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -25.35% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.53 M Net Income (TTM) -2.66 M
ROE N/A ROA -525.66%
Gross Margin N/A Operating Margin -101.58%
Net Margin -174.02% Free Cash Flow (TTM) -642,704.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.02
Interest Coverage -29.40 Asset Turnover 3.02
Working Capital -7.51 M Tangible Book Value -7.49 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.91 Forward P/E N/A
P/B Ratio N/A P/S Ratio 1.59
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -26.56%
Market Cap 2.42 M Enterprise Value 2.42 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.24
FCF / Share -0.10 OCF / Share -0.10
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.00% FCF Conversion 24.19%
SBC-Adj. FCF -1.24 M Growth Momentum -64.51

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 594,768.0 5.86 M 3.86 M 6.55 M 1.92 M
Net Income -3.61 M -11.52 M -25.46 M -565,514.0 1.35 M
EPS (Diluted) -2.72 0.00
Gross Profit -2.43 M 2.68 M 842,145.0
Operating Income -2.84 M -11.44 M -25.15 M -533,823.0 630,766.0
EBITDA
R&D Expenses
SG&A Expenses
D&A 31,907.0 2.84 M 3.60 M 1.62 M 300,855.0
Interest Expense 52,239.0 83,046.0 276,932.0 18,289.0 382.0
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 805,500.0 3.94 M 6.59 M 16.28 M 14.72 M
Total Liabilities 3.14 M 413,933.0
Shareholders' Equity -6.62 M -3.87 M -509,883.0 10.59 M 10.18 M
Total Debt
Cash & Equivalents 57,815.0 257,998.0 490,280.0 687,338.0
Current Assets 418,773.0 2.60 M 265,163.0 15.79 M 748,264.0
Current Liabilities 3.06 M 3.68 M 2.98 M 1.56 M 413,933.0